Analyst Activity – Needham & Company LLC Lowers Its Price Target On NASDAQ:TCON – TRACON Pharmaceuticals (NASDAQ:TCON) to

ME Staff
-
0

Analyst Ratings For NASDAQ:TCON – TRACON Pharmaceuticals (NASDAQ:TCON)

Today, Needham & Company LLC lowered its price target on NASDAQ:TCON – TRACON Pharmaceuticals (NASDAQ:TCON) to per share.

Some recent analyst ratings include

  • 1/3/2017-Wells Fargo was Downgraded by analysts at Wells Fargo from a “Outperform ➝ Market Perform” rating to a “” rating.
  • 12/21/2016-Jefferies Group initiated coverage with a Buy rating.
  • 8/19/2016-BTIG Research initiated coverage with a Buy rating.

Recent Insider Trading Activity For NASDAQ:TCON – TRACON Pharmaceuticals (NASDAQ:TCON)
NASDAQ:TCON – TRACON Pharmaceuticals (NASDAQ:TCON) has insider ownership of 23.30% and institutional ownership of 37.87%.

  • On 3/27/2018 Enterprise Associates 14 New, Major Shareholder, bought 707,964 with an average share price of $2.70 per share and the total transaction amounting to $1,911,502.80.
  • On 6/2/2017 William R Larue, Director, sold 2,500 with an average share price of $2.69 per share and the total transaction amounting to $6,725.00.
  • On 11/29/2016 Peter W Sonsini, Major Shareholder, bought 869,565 with an average share price of $5.75 per share and the total transaction amounting to $4,999,998.75.
  • On 6/3/2016 Ronald L Shazer, Insider, sold 1,003 with an average share price of $7.48 per share and the total transaction amounting to $7,502.44.
  • On 10/16/2015 Jafco Super V3 Investment Limi, Major Shareholder, sold 1,500 with an average share price of $9.90 per share and the total transaction amounting to $14,850.00.
  • On 10/15/2015 Jafco Super V3 Investment Limi, Major Shareholder, sold 5,300 with an average share price of $10.16 per share and the total transaction amounting to $53,848.00.
  • On 10/13/2015 Jafco Super V3 Investment Limi, major shareholder, sold 3,168 with an average share price of $10.01 per share and the total transaction amounting to $31,711.68.

Recent Trading Activity for NASDAQ:TCON – TRACON Pharmaceuticals (NASDAQ:TCON)
Shares of NASDAQ:TCON – TRACON Pharmaceuticals closed the previous trading session at 2.48 down -0.03 1.00% with shares trading hands.